Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Baek YJ, Kim WJ, Ko JH, Lee YJ, et al. A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen. Vaccine 2023;41:1694-1702.
PMID: 36754764


Privacy Policy